Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Sorin Group has received the FDA approval to market the Reply family of dual and single chamber pacemakers.
Subscribe to our email newsletter
The Reply pacemaker which is said to be the world’s smallest dual chamber pacemaker at 8cc’s is Sorin Group’s next pacing evolution designed to reduce ventricular pacing and promote natural cardiac function.
Reply integrates Sorin Group’s new proprietary SafeR pacing mode. The SafeR technology builds on the Sorin Group’s AAISafeR pacing mode first introduced in Europe in September 2003.
In addition to SafeR, the Reply pacemaker is said to deliver advanced, automatic features such as SmartCheck, which lets the user automate follow up tests and provides comprehensive data reporting and recommendations.
The Reply pacemaker will be distributed in the US by ELA Medical, a Sorin Group company.
Fred Hrkac, president of cardiac rhythm management business at Sorin Group, said: “Reply and SafeR demonstrate Sorin Group’s continued commitment to driving innovation in cardiac rhythm management and reinforces our mission to continuously improve the treatment of bradycardia.”